Abstract: An electronic includes an electronic element, an encapsulation layer surrounding the electronic element, a first circuit structure, a second circuit structure and a connecting structure. The encapsulation layer has a top surface, a bottom surface and an opening, wherein a sidewall of the opening connects the top surface and the bottom surface. The first circuit structure is disposed at the top surface of the encapsulation layer. The second circuit structure is disposed at the bottom surface of the encapsulation layer. The connecting structure is disposed in the opening, wherein the electronic element is electrically connected to the second circuit structure through the first circuit structure and the connecting structure. The connecting structure includes a first sub layer and a second sub layer, the first sub layer is located between the encapsulation layer and the second sub layer, and the first sub layer covers the sidewall of the opening.

Abstract: An electronic device is provided. The electronic device includes a first substrate, a second substrate, a light-shielding layer, and a color filter layer. The second substrate is disposed opposite to the first substrate. The light-shielding layer is disposed on the second substrate and includes an opening area and a light-shielding area. The color filter layer is disposed on the second substrate and includes a first color filter unit. The first color filter unit includes a first portion and a second portion. In addition, the first portion is at least partially overlapped with the opening area, the second portion is overlapped with the light-shielding area, and there is a first gap between the first portion and the second portion.

Abstract: An electronic device is provided. The electronic device includes a first substrate, a second substrate, a light-shielding layer, and a color filter layer. The second substrate is disposed opposite to the first substrate. The light-shielding layer is disposed on the second substrate and includes an opening area and a light-shielding area. The color filter layer is disposed on the second substrate and includes a first color filter unit. The first color filter unit includes a first portion and a second portion. In addition, the first portion is at least partially overlapped with the opening area, the second portion is overlapped with the light-shielding area, and there is a first gap between the first portion and the second portion.

Abstract: Methods and compositions for modulating the mobilization of stem cells, particularly for promoting or increasing the mobilization of hematopoietic stem cells from the bone marrow to the peripheral blood are disclosed. In particular, the invention relates to the use of adrenergic agonists that act in concert with a mobilization compound or agent. The mobilization agent(s) may act to decrease the expression or function of the chemokine, CXCL12, or may act to block or antagonize CXCR4. The invention also relates to methods of using these compounds or agents for enhancing the mobilization of hematopoietic stem cells when harvesting of the stem cells is necessary for the treatment of diseases, disabilities or conditions whereby transplantation of such cells would be beneficial in ameliorating the symptoms associated with such diseases, disabilities or conditions. Methods of screening for novel agents and pharmaceutical compositions comprising these agents are also disclosed.

Abstract: Methods and compositions for modulating the mobilization of stem cells, particularly for promoting or increasing the mobilization of hematopoietic stem cells from the bone marrow to the peripheral blood are disclosed. In particular, the invention relates to the use of adrenergic agonists that act in concert with a mobilization compound or agent. The mobilization agent(s) may act to decrease the expression or function of the chemokine, CXCL12, or may act to block or antagonize CXCR4. The invention also relates to methods of using these compounds or agents for enhancing the mobilization of hematopoietic stem cells when harvesting of the stem cells is necessary for the treatment of diseases, disabilities or conditions whereby transplantation of such cells would be beneficial in ameliorating the symptoms associated with such diseases, disabilities or conditions. Methods of screening for novel agents and pharmaceutical compositions comprising these agents are also disclosed.